Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lantheus
MedTech
Production problems hamper Lantheus FDA approval of dx kit
The FDA dealt Lantheus’ bid for approval of its radiodiopharmaceutical diagnostic kit a setback due to manufacturing issues at a third-party facility.
Joseph Keenan
Jun 29, 2026 8:31am
Lantheus taps GE HealthCare to sell its PSMA PET tracer in Japan
Sep 24, 2025 11:30am
Ikena and Inmagene choose combined CEO—Chutes & Ladders
Jul 25, 2025 8:30am
ESMO: Lantheus' radiotherapy readout not enough to best Pluvicto
Sep 16, 2024 8:55am
Lantheus acquires Alzheimer’s PET diagnostic developer Meilleur
Jul 15, 2024 11:30am
Atai, Eli Lilly, Novartis & more—Chutes & Ladders
May 17, 2024 8:30am
